Francois Cedric's Form 4 filing
Apellis Pharmaceuticals, Inc.APLS · filed May 18, 2023
- Accession no.
- 0001127602-23-016189
- Filed
- May 18, 2023
- Trade date
- May 16-17, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.57M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Francois CedricCIK 0001658080 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | Common Stock | MOption exerciseAcquired | +30,000 | $2.67 | +$80,100 | 304,655 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −934 | $83.17F6 | −$77,680.78 | 303,721 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −1,800 | $83.85F7 | −$150,930 | 301,921 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −14,611 | $85.01F8 | −$1,242,081.11 | 287,310 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −3,007 | $85.90F9 | −$258,301.3 | 284,303 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −7,528 | $87.02F10 | −$655,086.56 | 276,775 | Direct | |
| May 16, 2023 | Common Stock | SSaleDisposed | −2,120 | $87.67F11 | −$185,860.4 | 274,655 | Direct | |
| May 17, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $2.67 | +$53,400 | 294,655 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 320,000 | Direct | |
| May 17, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 300,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F6
This transaction was executed in multiple trades at prices ranging from $82.500 - $83.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $83.500 - $84.450. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $ $84.545 - $85.520. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $85.550 - $86.540. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $86.550 - $87.490. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F11
This transaction was executed in multiple trades at prices ranging from $87.570 - $87.795. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.